VulnerabilityModified
CVE-2021-25921
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section.
MEDIUM 5.4EPSS 91.1%
Does this matter?
EPSS puts the probability of exploitation in the next 30 days at 91.1%, higher than 100% of all known CVEs. Patch or mitigate before the next change window.
Description
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.
- CVSS 3.1
- 5.4 MEDIUMCVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 91.10% probability · 100th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- open-emr/openemr
- Source
- vulnerabilitylab@mend.io
References
- https://github.com/openemr/openemr/commit/0fadc3e592d84bc9dfe9e0403f8bd6e3c7d8427fPatch, Third Party Advisory
- https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25921Third Party Advisory
- https://github.com/openemr/openemr/commit/0fadc3e592d84bc9dfe9e0403f8bd6e3c7d8427fPatch, Third Party Advisory
- https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25921Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.